nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepenzolate—Loperamide—POMC—multiple sclerosis	0.073	0.537	CrCbGaD
Mepenzolate—Aclidinium—BCHE—multiple sclerosis	0.063	0.463	CrCbGaD
Mepenzolate—Vision blurred—Fingolimod—multiple sclerosis	0.0268	0.0311	CcSEcCtD
Mepenzolate—Palpitations—Fingolimod—multiple sclerosis	0.0252	0.0291	CcSEcCtD
Mepenzolate—Mydriasis—Prednisolone—multiple sclerosis	0.025	0.0289	CcSEcCtD
Mepenzolate—Asthenia—Fingolimod—multiple sclerosis	0.0167	0.0193	CcSEcCtD
Mepenzolate—Dizziness—Fingolimod—multiple sclerosis	0.0154	0.0178	CcSEcCtD
Mepenzolate—Headache—Fingolimod—multiple sclerosis	0.0146	0.0169	CcSEcCtD
Mepenzolate—Erectile dysfunction—Mitoxantrone—multiple sclerosis	0.014	0.0162	CcSEcCtD
Mepenzolate—Drowsiness—Mitoxantrone—multiple sclerosis	0.0136	0.0157	CcSEcCtD
Mepenzolate—Confusional state—Cladribine—multiple sclerosis	0.0133	0.0154	CcSEcCtD
Mepenzolate—Tachycardia—Cladribine—multiple sclerosis	0.0129	0.0149	CcSEcCtD
Mepenzolate—Abdominal distension—Prednisolone—multiple sclerosis	0.0126	0.0146	CcSEcCtD
Mepenzolate—Insomnia—Cladribine—multiple sclerosis	0.0119	0.0138	CcSEcCtD
Mepenzolate—Somnolence—Cladribine—multiple sclerosis	0.0117	0.0136	CcSEcCtD
Mepenzolate—Abdominal distension—Triamcinolone—multiple sclerosis	0.0116	0.0134	CcSEcCtD
Mepenzolate—Abdominal distension—Methylprednisolone—multiple sclerosis	0.0115	0.0134	CcSEcCtD
Mepenzolate—Constipation—Cladribine—multiple sclerosis	0.0113	0.013	CcSEcCtD
Mepenzolate—Feeling abnormal—Cladribine—multiple sclerosis	0.0109	0.0126	CcSEcCtD
Mepenzolate—Urticaria—Cladribine—multiple sclerosis	0.0105	0.0121	CcSEcCtD
Mepenzolate—Vision blurred—Mitoxantrone—multiple sclerosis	0.01	0.0116	CcSEcCtD
Mepenzolate—Hypersensitivity—Cladribine—multiple sclerosis	0.00971	0.0112	CcSEcCtD
Mepenzolate—Asthenia—Cladribine—multiple sclerosis	0.00945	0.0109	CcSEcCtD
Mepenzolate—Abdominal distension—Prednisone—multiple sclerosis	0.00914	0.0106	CcSEcCtD
Mepenzolate—Feeling abnormal—Azathioprine—multiple sclerosis	0.00883	0.0102	CcSEcCtD
Mepenzolate—Confusional state—Mitoxantrone—multiple sclerosis	0.00873	0.0101	CcSEcCtD
Mepenzolate—Dizziness—Cladribine—multiple sclerosis	0.00871	0.0101	CcSEcCtD
Mepenzolate—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.00866	0.01	CcSEcCtD
Mepenzolate—Tachycardia—Mitoxantrone—multiple sclerosis	0.00845	0.00978	CcSEcCtD
Mepenzolate—Vomiting—Cladribine—multiple sclerosis	0.00838	0.0097	CcSEcCtD
Mepenzolate—Erectile dysfunction—Prednisone—multiple sclerosis	0.00836	0.00968	CcSEcCtD
Mepenzolate—Headache—Cladribine—multiple sclerosis	0.00825	0.00955	CcSEcCtD
Mepenzolate—Vision blurred—Prednisolone—multiple sclerosis	0.0082	0.0095	CcSEcCtD
Mepenzolate—Hypersensitivity—Azathioprine—multiple sclerosis	0.00789	0.00913	CcSEcCtD
Mepenzolate—Nausea—Cladribine—multiple sclerosis	0.00783	0.00906	CcSEcCtD
Mepenzolate—Somnolence—Mitoxantrone—multiple sclerosis	0.0077	0.00891	CcSEcCtD
Mepenzolate—Constipation—Mitoxantrone—multiple sclerosis	0.00741	0.00857	CcSEcCtD
Mepenzolate—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00714	0.00826	CcSEcCtD
Mepenzolate—Anaphylactic shock—Prednisolone—multiple sclerosis	0.0071	0.00822	CcSEcCtD
Mepenzolate—Dizziness—Azathioprine—multiple sclerosis	0.00708	0.0082	CcSEcCtD
Mepenzolate—Erectile dysfunction—Methotrexate—multiple sclerosis	0.00699	0.00809	CcSEcCtD
Mepenzolate—Tachycardia—Prednisolone—multiple sclerosis	0.00693	0.00803	CcSEcCtD
Mepenzolate—Urticaria—Mitoxantrone—multiple sclerosis	0.00688	0.00796	CcSEcCtD
Mepenzolate—Vomiting—Azathioprine—multiple sclerosis	0.00681	0.00788	CcSEcCtD
Mepenzolate—Drowsiness—Methotrexate—multiple sclerosis	0.00677	0.00783	CcSEcCtD
Mepenzolate—Headache—Azathioprine—multiple sclerosis	0.00671	0.00777	CcSEcCtD
Mepenzolate—Dry mouth—Triamcinolone—multiple sclerosis	0.00667	0.00771	CcSEcCtD
Mepenzolate—Confusional state—Methylprednisolone—multiple sclerosis	0.00657	0.00761	CcSEcCtD
Mepenzolate—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00653	0.00756	CcSEcCtD
Mepenzolate—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00652	0.00755	CcSEcCtD
Mepenzolate—Insomnia—Prednisolone—multiple sclerosis	0.00643	0.00744	CcSEcCtD
Mepenzolate—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00638	0.00738	CcSEcCtD
Mepenzolate—Tachycardia—Triamcinolone—multiple sclerosis	0.00638	0.00738	CcSEcCtD
Mepenzolate—Nausea—Azathioprine—multiple sclerosis	0.00636	0.00736	CcSEcCtD
Mepenzolate—Tachycardia—Methylprednisolone—multiple sclerosis	0.00636	0.00736	CcSEcCtD
Mepenzolate—Asthenia—Mitoxantrone—multiple sclerosis	0.00621	0.00719	CcSEcCtD
Mepenzolate—Vision blurred—Prednisone—multiple sclerosis	0.00596	0.0069	CcSEcCtD
Mepenzolate—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00593	0.00686	CcSEcCtD
Mepenzolate—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00593	0.00686	CcSEcCtD
Mepenzolate—Insomnia—Triamcinolone—multiple sclerosis	0.00591	0.00684	CcSEcCtD
Mepenzolate—Insomnia—Methylprednisolone—multiple sclerosis	0.0059	0.00682	CcSEcCtD
Mepenzolate—Feeling abnormal—Prednisolone—multiple sclerosis	0.00585	0.00678	CcSEcCtD
Mepenzolate—Tachycardia—Betamethasone—multiple sclerosis	0.00579	0.0067	CcSEcCtD
Mepenzolate—Tachycardia—Dexamethasone—multiple sclerosis	0.00579	0.0067	CcSEcCtD
Mepenzolate—Urticaria—Prednisolone—multiple sclerosis	0.00564	0.00653	CcSEcCtD
Mepenzolate—Vomiting—Mitoxantrone—multiple sclerosis	0.00551	0.00637	CcSEcCtD
Mepenzolate—Headache—Mitoxantrone—multiple sclerosis	0.00543	0.00628	CcSEcCtD
Mepenzolate—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00538	0.00623	CcSEcCtD
Mepenzolate—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00537	0.00622	CcSEcCtD
Mepenzolate—Insomnia—Betamethasone—multiple sclerosis	0.00536	0.00621	CcSEcCtD
Mepenzolate—Insomnia—Dexamethasone—multiple sclerosis	0.00536	0.00621	CcSEcCtD
Mepenzolate—Hypersensitivity—Prednisolone—multiple sclerosis	0.00523	0.00606	CcSEcCtD
Mepenzolate—Urticaria—Triamcinolone—multiple sclerosis	0.00519	0.00601	CcSEcCtD
Mepenzolate—Urticaria—Methylprednisolone—multiple sclerosis	0.00518	0.00599	CcSEcCtD
Mepenzolate—Anaphylactic shock—Prednisone—multiple sclerosis	0.00516	0.00598	CcSEcCtD
Mepenzolate—Nausea—Mitoxantrone—multiple sclerosis	0.00514	0.00595	CcSEcCtD
Mepenzolate—Tachycardia—Prednisone—multiple sclerosis	0.00504	0.00583	CcSEcCtD
Mepenzolate—Vision blurred—Methotrexate—multiple sclerosis	0.00498	0.00577	CcSEcCtD
Mepenzolate—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00489	0.00565	CcSEcCtD
Mepenzolate—Feeling abnormal—Betamethasone—multiple sclerosis	0.00489	0.00565	CcSEcCtD
Mepenzolate—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00481	0.00557	CcSEcCtD
Mepenzolate—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.0048	0.00556	CcSEcCtD
Mepenzolate—Urticaria—Dexamethasone—multiple sclerosis	0.00471	0.00545	CcSEcCtD
Mepenzolate—Urticaria—Betamethasone—multiple sclerosis	0.00471	0.00545	CcSEcCtD
Mepenzolate—Dizziness—Prednisolone—multiple sclerosis	0.0047	0.00544	CcSEcCtD
Mepenzolate—Asthenia—Triamcinolone—multiple sclerosis	0.00469	0.00543	CcSEcCtD
Mepenzolate—Asthenia—Methylprednisolone—multiple sclerosis	0.00468	0.00541	CcSEcCtD
Mepenzolate—Insomnia—Prednisone—multiple sclerosis	0.00467	0.0054	CcSEcCtD
Mepenzolate—Headache—Prednisolone—multiple sclerosis	0.00445	0.00515	CcSEcCtD
Mepenzolate—Constipation—Prednisone—multiple sclerosis	0.00441	0.00511	CcSEcCtD
Mepenzolate—Confusional state—Methotrexate—multiple sclerosis	0.00435	0.00504	CcSEcCtD
Mepenzolate—Dizziness—Triamcinolone—multiple sclerosis	0.00432	0.005	CcSEcCtD
Mepenzolate—Anaphylactic shock—Methotrexate—multiple sclerosis	0.00431	0.00499	CcSEcCtD
Mepenzolate—Dizziness—Methylprednisolone—multiple sclerosis	0.00431	0.00499	CcSEcCtD
Mepenzolate—Feeling abnormal—Prednisone—multiple sclerosis	0.00425	0.00492	CcSEcCtD
Mepenzolate—Asthenia—Dexamethasone—multiple sclerosis	0.00425	0.00492	CcSEcCtD
Mepenzolate—Asthenia—Betamethasone—multiple sclerosis	0.00425	0.00492	CcSEcCtD
Mepenzolate—Nausea—Prednisolone—multiple sclerosis	0.00422	0.00488	CcSEcCtD
Mepenzolate—Vomiting—Triamcinolone—multiple sclerosis	0.00415	0.00481	CcSEcCtD
Mepenzolate—Vomiting—Methylprednisolone—multiple sclerosis	0.00414	0.0048	CcSEcCtD
Mepenzolate—Urticaria—Prednisone—multiple sclerosis	0.0041	0.00475	CcSEcCtD
Mepenzolate—Headache—Triamcinolone—multiple sclerosis	0.00409	0.00474	CcSEcCtD
Mepenzolate—Headache—Methylprednisolone—multiple sclerosis	0.00408	0.00473	CcSEcCtD
Mepenzolate—Dizziness—Dexamethasone—multiple sclerosis	0.00392	0.00454	CcSEcCtD
Mepenzolate—Dizziness—Betamethasone—multiple sclerosis	0.00392	0.00454	CcSEcCtD
Mepenzolate—Insomnia—Methotrexate—multiple sclerosis	0.0039	0.00452	CcSEcCtD
Mepenzolate—Nausea—Triamcinolone—multiple sclerosis	0.00388	0.00449	CcSEcCtD
Mepenzolate—Nausea—Methylprednisolone—multiple sclerosis	0.00387	0.00448	CcSEcCtD
Mepenzolate—Somnolence—Methotrexate—multiple sclerosis	0.00384	0.00444	CcSEcCtD
Mepenzolate—Hypersensitivity—Prednisone—multiple sclerosis	0.0038	0.0044	CcSEcCtD
Mepenzolate—Vomiting—Betamethasone—multiple sclerosis	0.00377	0.00436	CcSEcCtD
Mepenzolate—Vomiting—Dexamethasone—multiple sclerosis	0.00377	0.00436	CcSEcCtD
Mepenzolate—Headache—Dexamethasone—multiple sclerosis	0.00371	0.0043	CcSEcCtD
Mepenzolate—Headache—Betamethasone—multiple sclerosis	0.00371	0.0043	CcSEcCtD
Mepenzolate—Asthenia—Prednisone—multiple sclerosis	0.0037	0.00429	CcSEcCtD
Mepenzolate—Feeling abnormal—Methotrexate—multiple sclerosis	0.00356	0.00412	CcSEcCtD
Mepenzolate—Nausea—Betamethasone—multiple sclerosis	0.00352	0.00408	CcSEcCtD
Mepenzolate—Nausea—Dexamethasone—multiple sclerosis	0.00352	0.00408	CcSEcCtD
Mepenzolate—Urticaria—Methotrexate—multiple sclerosis	0.00343	0.00397	CcSEcCtD
Mepenzolate—Dizziness—Prednisone—multiple sclerosis	0.00341	0.00395	CcSEcCtD
Mepenzolate—Vomiting—Prednisone—multiple sclerosis	0.00328	0.0038	CcSEcCtD
Mepenzolate—Headache—Prednisone—multiple sclerosis	0.00323	0.00374	CcSEcCtD
Mepenzolate—Hypersensitivity—Methotrexate—multiple sclerosis	0.00318	0.00368	CcSEcCtD
Mepenzolate—Asthenia—Methotrexate—multiple sclerosis	0.0031	0.00358	CcSEcCtD
Mepenzolate—Nausea—Prednisone—multiple sclerosis	0.00307	0.00355	CcSEcCtD
Mepenzolate—Dizziness—Methotrexate—multiple sclerosis	0.00285	0.0033	CcSEcCtD
Mepenzolate—Vomiting—Methotrexate—multiple sclerosis	0.00274	0.00318	CcSEcCtD
Mepenzolate—Headache—Methotrexate—multiple sclerosis	0.0027	0.00313	CcSEcCtD
Mepenzolate—Nausea—Methotrexate—multiple sclerosis	0.00256	0.00297	CcSEcCtD
